Search company, investor...

Founded Year

1982

Stage

Acquired | Acquired

Total Raised

$7.5M

About JGI

The Janis Group (JGI) provides enterprise application and business intelligence solutions. It offers human capital, financial, and supply chain solutions; and management consulting and compliancy management solutions; and functional and technical consulting services. In August 2011, The Janis Group was acquired by Symphony Corporation.

Headquarters Location

201 West Passaic Street

Rochelle Park, New Jersey, 07662,

United States

201-712-0505

Loading...

Loading...

JGI Patents

JGI has filed 3 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/9/2012

9/3/2013

Mobility devices, Personal transporters, Maya sites, Cycle types, Accessibility

Grant

Application Date

4/9/2012

Grant Date

9/3/2013

Title

Related Topics

Mobility devices, Personal transporters, Maya sites, Cycle types, Accessibility

Status

Grant

Latest JGI News

Joint Genome Institute accepting letters of intent for large-scale sequence-based genomic projects; focus on alternative fuels, global carbon cycling and biogeochemistry

Mar 16, 2011

Joint Genome Institute accepting letters of intent for large-scale sequence-based genomic projects; focus on alternative fuels, global carbon cycling and biogeochemistry 16 March 2011 The US Department of Energy’s (DOE) Joint Genome Institute’s (JGI) Community Sequencing Program (CSP) is now accepting letters of intent for large-scale sequence based genomic science projects that address questions of relevance to DOE missions in alternative fuels, global carbon cycling and biogeochemistry. While applications will be accepted that address any aspect of these mission areas, up to 50% of capacity for this call will be allocated for projects that address the following areas of special emphasis, and exploit the diversity of JGI capabilities: Plant and Plant-Microbe interactions: Plant phenotypes are likely to be strongly influenced by their associated microbes. Studies are encouraged that explore the interaction of plants with their rhizosphere communities and other microbes or fungi that affect bioenergy-relevant plant phenotypes. Plant resequencing or transcriptomic projects are of interest but whole-genome de novo plant sequencing projects are discouraged for this CSP call. Plant phenotypes of interest might include drought or salt tolerance, nutrient use, primary productivity, biomass composition or yield or recalcitrance. Microbial emission and capture of greenhouse gases: Bacteria, archaea, fungi, and algae are important consumers and producers of greenhouse gases in the environment. Studies are sought that will provide insight into global carbon, nitrogen, and methane cycles, and/or suggest novel strategies for carbon capture, nitrogen processing, or methane reduction from environmental sources. Metagenomics: Most microbes live in complex communities in oftentimes dynamic environments where the impact of changing environmental parameters on community structure and function are largely unknown. Proposals are encouraged that couple metagenomic analyses with measures of the active component of microbial populations and associated environmental biogeochemistry to explore dynamic changes in the active community composition and expressed metabolism of microbial communities in DOE mission-relevant areas. Such areas may include: Bioenergy-related plant-microbe interactions, carbon/nitrogen cycling and/or carbon sequestration processes in soils and sediments, and biogeochemical processes contributing to contaminant biotransformation and/or immobilization. CSP projects are expected to generate publicly available data that will answer important questions relevant to the organism/environment being sequenced, as well as providing the substrate for broader use by the DOE research community. CSP projects have historically provided a means for user communities to assemble and interact in collaborative ways. Proposals are encouraged involving combinations of the following features: a significant scale, large DNA/RNA sequencing need (100s of gigabases to terabases), engaging a large group of collaborators, involving more than a single species and requiring JGI capabilities in addition to genome sequencing. Overall JGI capacity is expected to be about 15 Terabases (Tb) of which as much as 10 Tb may be available for this CSP. Each proposal must carefully justify the amount of sequencing requested but no single proposal should expect more than a maximum of 1 Tb. JGI Capabilities. JGI employs almost exclusively next-generation short-read sequencing platforms, with very limited longer-read capabilities. The capabilities available for this call are listed below. Individual proposals may draw from one or more of these capabilities as needed to fulfill project goals but if longer read sequencing is needed, the burden is on the submitter to justify the request. Successful projects frequently exploit a combination of capabilities: Core Products Include: De Novo Sequencing of Fungal, Bacterial, and Archaeal Genomes Resequencing for Variation Detection

JGI Frequently Asked Questions (FAQ)

  • When was JGI founded?

    JGI was founded in 1982.

  • Where is JGI's headquarters?

    JGI's headquarters is located at 201 West Passaic Street, Rochelle Park.

  • What is JGI's latest funding round?

    JGI's latest funding round is Acquired.

  • How much did JGI raise?

    JGI raised a total of $7.5M.

  • Who are the investors of JGI?

    Investors of JGI include Symphony Corporation, HarbourVest Partners and Edison Partners.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.